Article thumbnail

Magneto-Optical Relaxation Measurements of Functionalized Nanoparticles as a Novel Biosensor

By Konstanze Aurich, Gunnar Glöckl, Stefan Nagel and Werner Weitschies

Abstract

Measurements of magneto-optical relaxation signals of magnetic nanoparticles functionalized with biomolecules are a novel biosensing tool. Upon transmission of a laser beam through a nanoparticle suspension in a pulsed magnetic field, the properties of the laser beam change. This can be detected by optical methods. Biomolecular binding events leading to aggregation of nanoparticles are ascertainable by calculating the relaxation time and from this, the hydrodynamic diameters of the involved particles from the optical signal. Interaction between insulin-like growth factor 1 (IGF-1) and its antibody was utilized for demonstration of the measurement setup applicability as an immunoassay. Furthermore, a formerly developed kinetic model was utilized in order to determine kinetic parameters of the interaction. Beside utilization of the method as an immunoassay it can be applied for the characterization of diverse magnetic nanoparticles regarding their size and size distribution

Topics: Article
Publisher: Molecular Diversity Preservation International (MDPI)
OAI identifier: oai:pubmedcentral.nih.gov:3291896
Provided by: PubMed Central

Suggested articles

Citations

  1. (2008). Affinity analysis for biomolecular interactions based on magneto-optical relaxation measurements. Nanotechnology.
  2. (1982). Agglomerate formation in a magnetic fluid.
  3. (2002). An integrated microfluidic biochemical detection system for protein analysis with magnetic bead-based sampling capabilities. Lab Chip.
  4. (2000). Antibody arrays for high-throughput screening of antibody-antigen interactions.
  5. (2004). Biomolecular reactions studied using changes in Brownian rotation dynamics of magnetic particles.
  6. (2000). Cancer and insulin-like growth factor-I. A potential mechanism linking the environment with cancer risk. BMJ
  7. (2008). Characterization of superparamagnetic Fe3O4 nanoparticles by fluxgate magnetorelaxometry for use in biomedical applications.
  8. (2006). Comparison of reversible and irreversible dipolar assemblies in a ferrofluid.
  9. (2003). Deregulation of the IGF axis in cancer: epidemiological evidence and potential therapeutic interventions.
  10. (1999). Detection of magnetic nanoparticles with superSconducting quantum interference device (SQUID) magnetometer and application to immunoassays.
  11. (1997). Determination of relaxing or remanent nanoparticle magnetization provides a novel binding-specific technique for the evaluation of immunoassays.
  12. (2007). Development of a sensitive micro-magnetic chemiluminescence enzyme immunoassay for the determination of carcinoembryonic antigen.
  13. (2002). Direct comparison of binding equilibrium, thermodynamic, and rate constants determined by surface- and solution-based biophysical methods. Protein Sci.
  14. (1994). Direct force measurements of specific and nonspecific protein interactions. Biochemistry
  15. (1999). Effect of recombinant human growth hormone and insulin-like growth factor-1 administration on IGF-1 and IGFbinding protein-3 levels in brain injury. Pharmacotherapy
  16. (2006). Expression and characterization of insulin growth factor-1-enhanced green flourescent protein fused protein as a tracer for immunoassay.
  17. (1997). Functional epitope mapping of insulin-like growth factor I (IGF-I) by anti-IGF-I monoclonal antibodies. Endocrinology
  18. (2001). Guidance for Industry - Bioanalytical Method Validation; U.S. Department of Health and Human Services - Food and Drug Administration:
  19. (1999). Improving biosensor analysis.
  20. (2004). Insulin-like growth factor I levels in healthy adults. Horm Res.
  21. (2004). Insulin-like growth factor I levels in healthy children. Horm Res.
  22. (2008). Magnetic labeling, detection, and system integration.
  23. (1998). Measurement of an analog of insulin-like growth factor-I in blood plasma using a novel enzyme-linked immunosorbent assay.
  24. (2000). Monitoring of biological binding reactions by magneto-optical relaxation measurements. Magnetohydrodynamics
  25. (2004). Nanoparticle composition of a ferrofluid and its effects on the magnetic properties. Langmuir.
  26. (1907). New optical property (magnetic birefringence) of certain noncolloidal organic liquids. CR Hebd Seances Acad. Sci.
  27. (2009). Pitfalls of insulin-like growth factor I assays. Horm Res.
  28. (2001). Plasma level of IGF-1 in type 2 diabetic patients with neuropathy. Guangdong Yixue
  29. (2006). Quantitative evaluation of magnetic immunoassay with remanence measurement.
  30. (2004). Quantitative mass spectrometric immunoassay of insulin like growth factor 1. J. Proteome Res.
  31. (2000). Stability and stabilization of globular proteins in solution.
  32. (2002). Surfactant-protein interactions. In Rational design of stable protein formulations-theory and practice;
  33. (2001). The somatomedin hypothesis:
  34. (2000). Ultrasensitive magnetic biosensor for homogeneous immunoassay.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.